Webinar | Intermediate Risk Bladder Cancer: Understanding Your Treatment Options
This webinar presents an overview of risk classification and treatment options for patients with intermediate‑risk non‑muscle‑invasive bladder cancer (NMIBC).
Dr. Joshua Meeks discusses how intermediate‑risk NMIBC is defined, the risk classification system, recurrence statistics, and potential treatment strategies such as intravesical therapy and surgical optimization. The webinar emphasizes individualized patient counseling and the need for better therapeutic options in this heterogeneous group.
Intermediate‑risk NMIBC presents a significant burden due to high recurrence rates and limited curative options. Improving understanding and treatment of this group has the potential to reduce unnecessary procedures and improve patient quality of life.
Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.